image
image
user-login
arrow
RESTRIVA PUERTO RICO PHARMACEUTICAL, INC.

RESTRIVA
PUERTO RICO PHARMACEUTICAL, INC.

RESTRIVA is a DEVICE Trademark filed on Jan 31, 2022 in MAHARASHTRA through Puerto RICO IP Office.The Trademark is registered to PUERTO RICO PHARMACEUTICAL, INC. and was filed by attorney.

RESTRIVA PUERTO RICO PHARMACEUTICAL, INC. Trademark Information

Application ID

5306809

Status

Objected

Date of Application

Jan 31, 2022

Classes

5

Proprietor(s)

PUERTO RICO PHARMACEUTICAL, INC.

Type

DEVICE

Registration State

MAHARASHTRA

Country

Puerto RICO

IP Office

MUMBAI

Used Since

24/05/2016

FAQs

The application for RESTRIVA was made on Jan 31, 2022
The trademark applicant for RESTRIVA is PUERTO RICO PHARMACEUTICAL, INC..
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Objected.
Listed application Id of RESTRIVA is 5306809.
RESTRIVA Trademark is a DEVICE mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.